Adaptive Biotechnologies Corporation (ADPT) and Tenax Therapeutics Inc. (NASDAQ:TENX) Comparing side by side

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) and Tenax Therapeutics Inc. (NASDAQ:TENX), are influenced by compare since they are both players in the Biotechnology. These factors are particularly influence the profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation of the two firms.

Earnings & Valuation

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Adaptive Biotechnologies Corporation 28 0.00 61.12M -0.44 0.00
Tenax Therapeutics Inc. 1 0.00 6.30M -7.65 0.00

Table 1 showcases the top-line revenue, earnings per share and valuation of Adaptive Biotechnologies Corporation and Tenax Therapeutics Inc.


Table 2 provides us Adaptive Biotechnologies Corporation and Tenax Therapeutics Inc.’s return on assets, net margins and return on equity.

Net Margins Return on Equity Return on Assets
Adaptive Biotechnologies Corporation 220,014,398.85% 0% 0%
Tenax Therapeutics Inc. 518,603,885.41% -175.2% -156.5%


The Current Ratio and a Quick Ratio of Adaptive Biotechnologies Corporation are 7.3 and 7.1. Competitively, Tenax Therapeutics Inc. has 11 and 11 for Current and Quick Ratio. Tenax Therapeutics Inc.’s better ability to pay short and long-term obligations than Adaptive Biotechnologies Corporation.

Insider and Institutional Ownership

Roughly 46.2% of Adaptive Biotechnologies Corporation shares are owned by institutional investors while 22.2% of Tenax Therapeutics Inc. are owned by institutional investors. About 4.7% of Adaptive Biotechnologies Corporation’s share are owned by insiders. Competitively, 4.73% are Tenax Therapeutics Inc.’s share owned by insiders.


In this table we show the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Adaptive Biotechnologies Corporation -4.53% -3.87% 0% 0% 0% -4.34%
Tenax Therapeutics Inc. -2.96% -6.43% -21.56% 11.97% -79.3% 8.26%

For the past year Adaptive Biotechnologies Corporation had bearish trend while Tenax Therapeutics Inc. had bullish trend.


Adaptive Biotechnologies Corporation beats on 5 of the 9 factors Tenax Therapeutics Inc.

Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the identification, development, and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.